Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker RVMDW
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 9,889 | $192.84 | $1.9M Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 9,486 | $191.94 | $1.8M Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 500 | $190.99 | $95.5K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 200 | $189.17 | $37.8K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 600 | $187.34 | $112.4K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 400 | $186.41 | $74.6K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 800 | $185.04 | $148.0K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 1,900 | $184.02 | $349.6K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 2,700 | $182.87 | $493.8K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 5,776 | $182.09 | $1.1M Sale | Form 4 ↗ |
| Nov 11, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 3,499 | $181.04 | $633.5K Sale | Form 4 ↗ |
| Nov 9, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 811 | $200.00 | $162.2K Sale | Form 4 ↗ |
| Oct 26, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 2,310 | $186.99 | $431.9K Sale | Form 4 ↗ |
| Sep 25, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 3,121 | $200.54 | $625.9K Sale | Form 4 ↗ |
| Sep 25, 2026 | Jeff Cislini SVP & General Counsel | RVMD Revolution Medicines, Inc. | Sale | 765 | $207.32 | $158.6K Sale | Form 4 ↗ |
| Sep 24, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 587 | $200.00 | $117.4K Sale | Form 4 ↗ |
| Sep 22, 2026 | Elizabeth M. Anderson Director | RVMD Revolution Medicines, Inc. | Sale | 100 | $195.15 | $19.5K Sale | Form 4 ↗ |
| Sep 22, 2026 | Elizabeth M. Anderson Director | RVMD Revolution Medicines, Inc. | Sale | 1,500 | $194.59 | $291.9K Sale | Form 4 ↗ |
| Sep 22, 2026 | Elizabeth M. Anderson Director | RVMD Revolution Medicines, Inc. | Sale | 2,648 | $193.44 | $512.2K Sale | Form 4 ↗ |
| Sep 22, 2026 | Elizabeth M. Anderson Director | RVMD Revolution Medicines, Inc. | Sale | 4,985 | $192.54 | $959.8K Sale | Form 4 ↗ |
| Sep 22, 2026 | Elizabeth M. Anderson Director | RVMD Revolution Medicines, Inc. | Sale | 910 | $191.85 | $174.6K Sale | Form 4 ↗ |
| Sep 18, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 1,764 | $196.94 | $347.4K Sale | Form 4 ↗ |
| Sep 16, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 1,747 | $199.30 | $348.2K Sale | Form 4 ↗ |
| Sep 16, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 27 | $195.05 | $5,266 Sale | Form 4 ↗ |
| Sep 16, 2026 | Jeff Cislini SVP & General Counsel | RVMD Revolution Medicines, Inc. | Sale | 3,314 | $199.30 | $660.5K Sale | Form 4 ↗ |
| Sep 16, 2026 | Jeff Cislini SVP & General Counsel | RVMD Revolution Medicines, Inc. | Sale | 52 | $195.01 | $10.1K Sale | Form 4 ↗ |
| Sep 16, 2026 | Alan B. Sandler Chief Development Officer | RVMD Revolution Medicines, Inc. | Sale | 336 | $199.30 | $67.0K Sale | Form 4 ↗ |
| Sep 16, 2026 | Alan B. Sandler Chief Development Officer | RVMD Revolution Medicines, Inc. | Sale | 5 | $194.96 | $975 Sale | Form 4 ↗ |
| Sep 16, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 3,992 | $199.30 | $795.6K Sale | Form 4 ↗ |
| Sep 16, 2026 | Jack Anders Chief Financial Officer | RVMD Revolution Medicines, Inc. | Sale | 61 | $195.00 | $11.9K Sale | Form 4 ↗ |
| Sep 16, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 5,484 | $199.30 | $1.1M Sale | Form 4 ↗ |
| Sep 16, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 85 | $195.01 | $16.6K Sale | Form 4 ↗ |
| Sep 16, 2026 | Margaret A. Horn Chief Operating Officer | RVMD Revolution Medicines, Inc. | Sale | 4,891 | $199.30 | $974.8K Sale | Form 4 ↗ |
| Sep 16, 2026 | Margaret A. Horn Chief Operating Officer | RVMD Revolution Medicines, Inc. | Sale | 76 | $195.01 | $14.8K Sale | Form 4 ↗ |
| Sep 16, 2026 | Mark A. Goldsmith See Remarks, Director | RVMD Revolution Medicines, Inc. | Sale | 13,775 | $199.30 | $2.7M Sale | Form 4 ↗ |
| Sep 16, 2026 | Mark A. Goldsmith See Remarks, Director | RVMD Revolution Medicines, Inc. | Sale | 213 | $195.01 | $41.5K Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 3,270 | $205.81 | $673.0K Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 4,995 | $204.84 | $1.0M Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 17,949 | $203.87 | $3.7M Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 18,869 | $203.06 | $3.8M Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 21,447 | $201.75 | $4.3M Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 13,368 | $200.78 | $2.7M Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 11,833 | $200.11 | $2.4M Sale | Form 4 ↗ |
| Sep 11, 2026 | Stephen Michael Kelsey See Remarks | RVMD Revolution Medicines, Inc. | Sale | 800 | $198.55 | $158.8K Sale | Form 4 ↗ |
| Sep 10, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 300 | $207.17 | $62.2K Sale | Form 4 ↗ |
| Sep 10, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 1,179 | $206.10 | $243.0K Sale | Form 4 ↗ |
| Sep 10, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 2,420 | $205.05 | $496.2K Sale | Form 4 ↗ |
| Sep 10, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 5,530 | $204.14 | $1.1M Sale | Form 4 ↗ |
| Sep 10, 2026 | Anthony Mancini See Remarks | RVMD Revolution Medicines, Inc. | Sale | 6,019 | $203.28 | $1.2M Sale | Form 4 ↗ |
| Sep 8, 2026 | Lorence H. Kim Director | RVMD Revolution Medicines, Inc. | Sale | 371 | $212.27 | $78.8K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:16 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances